Anjali Katyal Nath, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cyanides | 5 | 2023 | 82 | 1.870 |
Why?
|
| Antidotes | 3 | 2023 | 138 | 1.120 |
Why?
|
| Zebrafish | 7 | 2023 | 3035 | 0.960 |
Why?
|
| Poisoning | 1 | 2023 | 254 | 0.750 |
Why?
|
| Carnitine | 1 | 2019 | 253 | 0.610 |
Why?
|
| Sarcopenia | 1 | 2023 | 378 | 0.590 |
Why?
|
| Glucose | 3 | 2019 | 4340 | 0.420 |
Why?
|
| Glyoxylates | 2 | 2023 | 12 | 0.420 |
Why?
|
| Riboflavin | 1 | 2013 | 106 | 0.400 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 1245 | 0.390 |
Why?
|
| Cisplatin | 1 | 2017 | 1655 | 0.360 |
Why?
|
| Cardiovascular System | 2 | 2009 | 839 | 0.340 |
Why?
|
| Endocardial Cushions | 1 | 2008 | 12 | 0.310 |
Why?
|
| Homeostasis | 1 | 2019 | 3342 | 0.310 |
Why?
|
| Nitric Oxide | 3 | 2009 | 2141 | 0.300 |
Why?
|
| Leptin | 5 | 2008 | 1596 | 0.260 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2019 | 2456 | 0.250 |
Why?
|
| Insulin Resistance | 1 | 2019 | 3989 | 0.250 |
Why?
|
| Neovascularization, Physiologic | 5 | 2004 | 1368 | 0.250 |
Why?
|
| Mesoderm | 1 | 2008 | 679 | 0.240 |
Why?
|
| Yolk Sac | 1 | 2004 | 79 | 0.230 |
Why?
|
| Epithelium | 1 | 2008 | 1606 | 0.210 |
Why?
|
| Myography | 1 | 2023 | 111 | 0.200 |
Why?
|
| Rabbits | 3 | 2022 | 4752 | 0.190 |
Why?
|
| Platinum | 1 | 2022 | 219 | 0.180 |
Why?
|
| Receptor, TIE-2 | 1 | 2021 | 183 | 0.180 |
Why?
|
| Protective Agents | 1 | 2021 | 150 | 0.180 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2019 | 82 | 0.170 |
Why?
|
| Metabolomics | 3 | 2021 | 1675 | 0.160 |
Why?
|
| Potassium Cyanide | 1 | 2018 | 17 | 0.160 |
Why?
|
| Electric Impedance | 1 | 2023 | 791 | 0.150 |
Why?
|
| Animals | 21 | 2023 | 168930 | 0.150 |
Why?
|
| Anti-Obesity Agents | 1 | 2021 | 241 | 0.150 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2018 | 64 | 0.150 |
Why?
|
| Atrophy | 1 | 2023 | 1631 | 0.150 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2009 | 3609 | 0.140 |
Why?
|
| Lethal Dose 50 | 1 | 2017 | 71 | 0.140 |
Why?
|
| Electron Transport Complex IV | 1 | 2017 | 188 | 0.140 |
Why?
|
| Sulfur | 1 | 2017 | 158 | 0.130 |
Why?
|
| Heart Defects, Congenital | 2 | 2011 | 4712 | 0.130 |
Why?
|
| Solubility | 1 | 2017 | 1078 | 0.120 |
Why?
|
| Swine | 2 | 2023 | 5987 | 0.120 |
Why?
|
| Proteomics | 1 | 2009 | 3914 | 0.120 |
Why?
|
| Gene Deletion | 2 | 2019 | 2669 | 0.110 |
Why?
|
| Signal Transduction | 4 | 2021 | 23619 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 1 | 2004 | 2631 | 0.110 |
Why?
|
| Nitroprusside | 1 | 2013 | 271 | 0.100 |
Why?
|
| Endothelium, Vascular | 5 | 2005 | 4424 | 0.100 |
Why?
|
| Hemodynamics | 1 | 2023 | 4188 | 0.100 |
Why?
|
| Inosine | 1 | 2013 | 129 | 0.100 |
Why?
|
| Zebrafish Proteins | 1 | 2018 | 1018 | 0.100 |
Why?
|
| Spectrin | 1 | 2011 | 175 | 0.090 |
Why?
|
| Metabolome | 1 | 2018 | 1009 | 0.090 |
Why?
|
| Oxidation-Reduction | 1 | 2017 | 2221 | 0.090 |
Why?
|
| Proteome | 1 | 2021 | 1894 | 0.090 |
Why?
|
| Bile Acids and Salts | 1 | 2013 | 398 | 0.090 |
Why?
|
| Overweight | 1 | 2021 | 2446 | 0.090 |
Why?
|
| Drug Approval | 1 | 2017 | 820 | 0.080 |
Why?
|
| Endothelial Cells | 2 | 2021 | 3581 | 0.080 |
Why?
|
| Neural Tube Defects | 1 | 2011 | 256 | 0.080 |
Why?
|
| Capillaries | 2 | 2002 | 755 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2023 | 4970 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 1331 | 0.070 |
Why?
|
| Mice | 13 | 2022 | 81889 | 0.070 |
Why?
|
| Amniotic Fluid | 1 | 2009 | 381 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2011 | 1129 | 0.070 |
Why?
|
| Endothelial Growth Factors | 4 | 2002 | 671 | 0.070 |
Why?
|
| Embryo, Mammalian | 2 | 2011 | 1675 | 0.070 |
Why?
|
| STAT2 Transcription Factor | 1 | 2005 | 27 | 0.060 |
Why?
|
| Lymphokines | 4 | 2002 | 924 | 0.060 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 1767 | 0.060 |
Why?
|
| Insulin | 1 | 2019 | 6608 | 0.060 |
Why?
|
| Chromatography, Liquid | 1 | 2009 | 996 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 20144 | 0.060 |
Why?
|
| Carrier Proteins | 3 | 2011 | 4924 | 0.060 |
Why?
|
| STAT1 Transcription Factor | 1 | 2005 | 340 | 0.060 |
Why?
|
| Antineoplastic Agents | 2 | 2022 | 13643 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 18330 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2004 | 420 | 0.050 |
Why?
|
| Cell Line | 1 | 2017 | 15563 | 0.050 |
Why?
|
| Autocrine Communication | 1 | 2003 | 168 | 0.050 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2002 | 88 | 0.050 |
Why?
|
| Paracrine Communication | 1 | 2003 | 277 | 0.050 |
Why?
|
| Sulfides | 1 | 2022 | 169 | 0.050 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2022 | 250 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 2198 | 0.050 |
Why?
|
| Interferon-alpha | 1 | 2005 | 910 | 0.050 |
Why?
|
| Sulfonic Acids | 1 | 2021 | 103 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2004 | 911 | 0.050 |
Why?
|
| Pyruvic Acid | 1 | 2022 | 205 | 0.050 |
Why?
|
| Pregnancy | 3 | 2009 | 30237 | 0.050 |
Why?
|
| Blastocyst | 1 | 2004 | 432 | 0.050 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2002 | 254 | 0.050 |
Why?
|
| Microcirculation | 1 | 2005 | 1282 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2002 | 3511 | 0.040 |
Why?
|
| Angiopoietin-2 | 1 | 2021 | 186 | 0.040 |
Why?
|
| Zinc Fingers | 1 | 2002 | 577 | 0.040 |
Why?
|
| Receptors, Cell Surface | 2 | 2000 | 2815 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2006 | 1121 | 0.040 |
Why?
|
| Obesity | 1 | 2021 | 13090 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 4 | 2002 | 748 | 0.040 |
Why?
|
| Protein Engineering | 1 | 2002 | 554 | 0.040 |
Why?
|
| Vitreous Body | 1 | 2000 | 401 | 0.040 |
Why?
|
| Diet, Reducing | 1 | 2021 | 487 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 1646 | 0.040 |
Why?
|
| Humans | 14 | 2023 | 766766 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2005 | 3158 | 0.030 |
Why?
|
| Cysteine | 1 | 2021 | 896 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 12245 | 0.030 |
Why?
|
| Mammals | 1 | 2022 | 1133 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2002 | 1749 | 0.030 |
Why?
|
| Retinal Detachment | 1 | 2000 | 429 | 0.030 |
Why?
|
| Cell Movement | 1 | 2008 | 5199 | 0.030 |
Why?
|
| Aniline Compounds | 1 | 2021 | 1079 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2002 | 1494 | 0.030 |
Why?
|
| Ligands | 1 | 2022 | 3275 | 0.030 |
Why?
|
| Gene Expression Regulation | 5 | 2005 | 11920 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2000 | 1071 | 0.030 |
Why?
|
| Skin | 2 | 2005 | 4499 | 0.030 |
Why?
|
| Proteins | 2 | 2000 | 6002 | 0.030 |
Why?
|
| Vascular Diseases | 1 | 2021 | 1161 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2002 | 12150 | 0.030 |
Why?
|
| Female | 8 | 2021 | 396520 | 0.030 |
Why?
|
| Wound Healing | 1 | 2003 | 2800 | 0.020 |
Why?
|
| Neuroepithelial Cells | 1 | 2011 | 23 | 0.020 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2002 | 2057 | 0.020 |
Why?
|
| Cells, Cultured | 6 | 2005 | 18984 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 7609 | 0.020 |
Why?
|
| Ankyrins | 1 | 2011 | 123 | 0.020 |
Why?
|
| Pseudopodia | 1 | 2011 | 168 | 0.020 |
Why?
|
| Diabetic Retinopathy | 1 | 2000 | 1300 | 0.020 |
Why?
|
| Weight Loss | 1 | 2021 | 2712 | 0.020 |
Why?
|
| Protein Stability | 1 | 2011 | 578 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 8540 | 0.020 |
Why?
|
| Craniofacial Abnormalities | 1 | 2011 | 320 | 0.020 |
Why?
|
| Gene Expression | 1 | 2021 | 7585 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 22352 | 0.020 |
Why?
|
| Heart Failure | 1 | 2013 | 11882 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2011 | 637 | 0.020 |
Why?
|
| Apoptosis | 2 | 2005 | 9513 | 0.020 |
Why?
|
| Myocardium | 1 | 2001 | 4765 | 0.020 |
Why?
|
| Receptors, Leptin | 2 | 2000 | 352 | 0.020 |
Why?
|
| Heart | 1 | 2001 | 4425 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2021 | 12430 | 0.020 |
Why?
|
| Body Patterning | 1 | 2011 | 634 | 0.020 |
Why?
|
| Fibroblasts | 2 | 2011 | 4166 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2011 | 722 | 0.020 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2005 | 110 | 0.020 |
Why?
|
| Models, Animal | 2 | 2002 | 2121 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2005 | 348 | 0.010 |
Why?
|
| Molecular Sequence Data | 3 | 2002 | 17608 | 0.010 |
Why?
|
| Actins | 1 | 2011 | 2060 | 0.010 |
Why?
|
| Middle Aged | 4 | 2021 | 223257 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2021 | 13050 | 0.010 |
Why?
|
| Axons | 1 | 2011 | 1675 | 0.010 |
Why?
|
| Cell Division | 2 | 2002 | 4474 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 2005 | 656 | 0.010 |
Why?
|
| Cell Proliferation | 2 | 2011 | 10445 | 0.010 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2005 | 856 | 0.010 |
Why?
|
| Lung | 1 | 2021 | 10067 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2005 | 547 | 0.010 |
Why?
|
| Lipoproteins, LDL | 1 | 2005 | 642 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2011 | 3641 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2002 | 1082 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2002 | 287 | 0.010 |
Why?
|
| Phenotype | 2 | 2011 | 16724 | 0.010 |
Why?
|
| Response Elements | 1 | 2002 | 308 | 0.010 |
Why?
|
| Cadherins | 1 | 2005 | 902 | 0.010 |
Why?
|
| Epiretinal Membrane | 1 | 2000 | 73 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 2000 | 861 | 0.010 |
Why?
|
| Mitogens | 1 | 2000 | 229 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2005 | 3073 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2005 | 12791 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 59550 | 0.010 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2000 | 200 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 2002 | 13411 | 0.010 |
Why?
|
| Rats, Zucker | 1 | 1998 | 130 | 0.010 |
Why?
|
| Adult | 3 | 2021 | 223307 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2002 | 627 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 2629 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4570 | 0.010 |
Why?
|
| Models, Biological | 2 | 2005 | 9461 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41710 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2000 | 591 | 0.010 |
Why?
|
| Male | 4 | 2021 | 364142 | 0.010 |
Why?
|
| Gene Expression Profiling | 2 | 2005 | 9525 | 0.010 |
Why?
|
| Drug Design | 1 | 2002 | 1042 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2000 | 1697 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3796 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2001 | 1892 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2000 | 2551 | 0.010 |
Why?
|
| Corneal Neovascularization | 1 | 1998 | 184 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2000 | 1337 | 0.010 |
Why?
|
| Mice, Knockout | 2 | 2002 | 14471 | 0.010 |
Why?
|
| Antibodies | 1 | 2003 | 2421 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2000 | 2628 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2005 | 5890 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2005 | 4032 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 65273 | 0.010 |
Why?
|
| Young Adult | 1 | 2021 | 59939 | 0.010 |
Why?
|
| STAT3 Transcription Factor | 1 | 1998 | 872 | 0.010 |
Why?
|
| Chromatin | 1 | 2005 | 2977 | 0.010 |
Why?
|
| Risk Factors | 1 | 2021 | 74881 | 0.010 |
Why?
|
| Binding Sites | 1 | 2002 | 6012 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 6507 | 0.010 |
Why?
|
| Aged | 2 | 2021 | 171343 | 0.010 |
Why?
|
| Adipocytes | 1 | 1998 | 1196 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 12415 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 5789 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 1998 | 1895 | 0.010 |
Why?
|
| Cell Survival | 1 | 2000 | 5748 | 0.010 |
Why?
|
| Trans-Activators | 1 | 1998 | 2855 | 0.000 |
Why?
|
| Neoplasm Proteins | 1 | 2000 | 3601 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 11061 | 0.000 |
Why?
|
| Phosphorylation | 1 | 1998 | 8307 | 0.000 |
Why?
|
| Energy Metabolism | 1 | 1998 | 2903 | 0.000 |
Why?
|
| Rats | 1 | 1998 | 23717 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 1998 | 9611 | 0.000 |
Why?
|
| Child | 1 | 2000 | 80668 | 0.000 |
Why?
|
| Adolescent | 1 | 2000 | 88904 | 0.000 |
Why?
|